Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Utah Medical Products (UTMD) Revenue (2016 - 2025)

Historic Revenue for Utah Medical Products (UTMD) over the last 16 years, with Q3 2025 value amounting to $9.8 million.

  • Utah Medical Products' Revenue fell 192.9% to $9.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $38.6 million, marking a year-over-year decrease of 1235.54%. This contributed to the annual value of $40.9 million for FY2024, which is 1855.89% down from last year.
  • Latest data reveals that Utah Medical Products reported Revenue of $9.8 million as of Q3 2025, which was down 192.9% from $10.0 million recorded in Q2 2025.
  • In the past 5 years, Utah Medical Products' Revenue ranged from a high of $13.6 million in Q4 2022 and a low of $9.2 million during Q4 2024
  • For the 5-year period, Utah Medical Products' Revenue averaged around $11.7 million, with its median value being $12.3 million (2023).
  • Its Revenue has fluctuated over the past 5 years, first surged by 4343.92% in 2021, then crashed by 2575.2% in 2024.
  • Quarter analysis of 5 years shows Utah Medical Products' Revenue stood at $12.9 million in 2021, then rose by 5.12% to $13.6 million in 2022, then decreased by 9.15% to $12.3 million in 2023, then fell by 25.75% to $9.2 million in 2024, then grew by 7.15% to $9.8 million in 2025.
  • Its Revenue was $9.8 million in Q3 2025, compared to $10.0 million in Q2 2025 and $9.7 million in Q1 2025.